Actions That Lead to an Excellent Diagnostic Experience Explored by The Beryl Institute

NASHVILLE, Tenn., Nov. 5, 2020 /PRNewswire-PRWeb/ -- Reinforcing its commitment to elevate the human experience in healthcare, The Beryl Institute publishes a new white paper, A Global Inquiry on Excellence in the Diagnostic Journey: The Power of Human Experience in Healthcare. This paper is grounded in accounts from healthcare leaders, clinicians, staff, patients and family members on the actions and efforts that lead to excellence in the diagnostic experience. The white paper evaluates the diagnostic experience from a range of lenses including the scheduling and timing of appointments or procedures, the process of the experience overall, the environment in which the experience occurs, communication and engagement during the diagnostic journey and how results and planning are managed.

The goal of this global inquiry was to identify what matters most throughout the diagnostic experience and to identify, compare and contrast perspectives to better understand and act in ways that benefit all in healthcare. This inquiry followed a two-phase approach, starting with a diverse focus group conversation to help frame the broader context. The focus group's responses then helped frame a survey that was conducted online.

The white paper illustrates key considerations for organizations and leaders to excel at the diagnostic experience, including:

• How you communicate matters.
• Take the time to be present for your patients.
• Understand the priorities of your patients.
• Ensure opportunities for partnership.

"It is in the ability of all in healthcare to remember the person traveling the diagnostic journey as just that: a human being with a story, loved ones, fears and dreams," said Jason Wolf, Ph.D., CPXP, President & CEO of The Beryl Institute. "Each life is unique, even in the most common of diagnostic processes; therefore, each experience is unlike any other. It is in our ability to be present for one another with the foundational processes in place that will ensure not only the best in diagnostic experience but the best in human experience is delivered."

To download the white paper, please visit: https://www.theberylinstitute.org/store/viewproduct.aspx?id=17422197

About The Beryl Institute:

The Beryl Institute is the global community of practice committed to elevating the human experience in healthcare. We believe human experience is grounded in experiences of patients & families, those who work in healthcare and the communities they serve. We define patient experience as the sum of all interactions, shaped by an organization's culture, that influence patient perceptions across the continuum of care.

About Siemens Healthineers:

Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) is shaping the future of Healthcare. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers enables healthcare providers worldwide through its regional companies to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving the patient experience, and digitalizing healthcare. Siemens Healthineers is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company's foundation in in-vitro diagnostic, image-guided therapy, and in-vivo diagnostics. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers' ability to provide high-quality, efficient care to patients. In fiscal 2019, which ended on September 30, 2019, Siemens Healthineers, which has approximately 52,000 employees worldwide, generated revenue of €14.5 billion and adjusted profit of €2.5 billion. Further information is available at http://www.siemens-healthineers.com

SOURCE The Beryl Institute